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T cell immune responses of HIV+ patients are functionally
impaired prior to CD4+ T cell depletion. Tryptophan (trp)
degradation by indoleamine-2, 3-dyoxigenase (IDO) is an
immunosuppressive system that may be important in
HIV/AIDS. We show here that IDO is increased in PBMC
from HIV+ patients compared to controls. Culture with
the IDO-inhibitor 1-methyl tryptophan (1 mT) increased
proliferation of PBMC from HIV+ patients in response to
PHA or anti-CD3/CD28. Exposure of PBMC from HIV-
uninfected donors to infectious or noninfectious HIV
increased IDO in plasmacytoid dendritic cells (pDC).
Supernatants from HIV-exposed PBMC inhibited CD4+ T
cell responses to PHA or anti-CD3/CD28, and this effect
was reversed by 1 mT. CD8+ T cell proliferation in
response to anti-CD3/CD28, but not to PHA, was also
inhibited. Analysis of cyclin mRNA expression showed
that CD4+ T cell were arrested in G1, whereas CD8+ T cell
were blocked in G0. HIV-induced IDO inhibited expres-
sion of CD28 mRNA in CD8+ T cells. Thus HIV directly
induces IDO expression in pDC, resulting in unrespon-
siveness of CD4+ T cells by inhibiting progression to the S
phase of the cell cycle, and blocking of CD8+ T cell cos-
timulation through downregulation of CD28.
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